Sorrento Therapeutics (NASDAQ:SRNE) Now Covered by Analysts at StockNews.com

Equities research analysts at StockNews.com assumed coverage on shares of Sorrento Therapeutics ( NASDAQ:SRNE – Get Free Report ) in a note issued to investors on Thursday. The firm set a “hold” rating on the biopharmaceutical company’s stock.

Sorrento Therapeutics Price Performance NASDAQ SRNE opened at $0.00 on Thursday. Sorrento Therapeutics has a fifty-two week low of $0.



00 and a fifty-two week high of $0.14. Sorrento Therapeutics Company Profile ( Get Free Report ) Featured Stories Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.

com's FREE daily email newsletter ..